PBI40 HEALTHCARE COSTS OF PATIENTS WITH PSORIATIC ARTHRITIS (PSA) TREATED WITH BIOLOGIC AGENTS OR TARGETED SYNTHETIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUG (TSDMARD) IN THE REAL WORLD

Saved in:
Bibliographic Details
Published in:Value in health 2020-05, Vol.23, p.S21-S21
Main Authors: Murage, M., Princic, N., Park, J., Malatestinic, B., Zhu, B., Atiya, B., Kern, S., Stenger, K., Sprabery, A.T., Ogdie-Beatty, A.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2020.04.103